Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas

Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas

Bibliographic Details
Main Authors: Songül Şerefhanoğlu, Ebru Koca, Hakan Goker, İbrahim Celalettin Haznedaroğlu, Deniz Çetiner, Nilgün Sayınalp, Yahya Büyükaşık, Osman İlhami Özcebe
Format: Article
Language:English
Published: Galenos Publishing House 2008-12-01
Series:Turkish Journal of Hematology
Subjects:
Ibritumomab Tiuxetan Radioimmunotherapy
NHL
Online Access:https://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-16443

Internet

https://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-16443

Similar Items